Jay Jalaram Technologies Limited

NSEI:KORE Stok Raporu

Piyasa değeri: ₹5.5b

Jay Jalaram Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Jay Jalaram Technologies has a total shareholder equity of ₹274.7M and total debt of ₹508.5M, which brings its debt-to-equity ratio to 185.1%. Its total assets and total liabilities are ₹1.5B and ₹1.2B respectively. Jay Jalaram Technologies's EBIT is ₹93.1M making its interest coverage ratio 2.5. It has cash and short-term investments of ₹67.9M.

Anahtar bilgiler

185.1%

Borç/özkaynak oranı

₹508.45m

Borç

Faiz karşılama oranı2.5x
Nakit₹67.93m
Eşitlik₹274.66m
Toplam yükümlülükler₹1.24b
Toplam varlıklar₹1.51b

Son finansal sağlık güncellemeleri

Recent updates

Does Jay Jalaram Technologies (NSE:KORE) Have A Healthy Balance Sheet?

Jul 23
Does Jay Jalaram Technologies (NSE:KORE) Have A Healthy Balance Sheet?

The Market Lifts Jay Jalaram Technologies Limited (NSE:KORE) Shares 29% But It Can Do More

Jun 15
The Market Lifts Jay Jalaram Technologies Limited (NSE:KORE) Shares 29% But It Can Do More

If EPS Growth Is Important To You, Jay Jalaram Technologies (NSE:KORE) Presents An Opportunity

Oct 20
If EPS Growth Is Important To You, Jay Jalaram Technologies (NSE:KORE) Presents An Opportunity

Fewer Investors Than Expected Jumping On Jay Jalaram Technologies Limited (NSE:KORE)

Jul 05
Fewer Investors Than Expected Jumping On Jay Jalaram Technologies Limited (NSE:KORE)

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: KORE's short term assets (₹1.4B) exceed its short term liabilities (₹807.4M).

Uzun Vadeli Yükümlülükler: KORE's short term assets (₹1.4B) exceed its long term liabilities (₹428.7M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: KORE's net debt to equity ratio (160.4%) is considered high.

Borcun Azaltılması: KORE's debt to equity ratio has reduced from 1758.2% to 185.1% over the past 5 years.

Borç Kapsamı: KORE's operating cash flow is negative, therefore debt is not well covered.

Faiz Kapsamı: KORE's interest payments on its debt are not well covered by EBIT (2.5x coverage).


Bilanço


Sağlıklı şirketleri keşfedin